Immunomonitoring and Multiple Myeloma: Impact of Lenalidomide on Immune Checkpoint Expression
Clinical trial NCT04872023 · COMPLETED
Trial details
- NCT number
- NCT04872023
- Sponsor
- Rennes University Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-29
- Primary completion
- 2022-06-13
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.